Brian F. Thomas, Ph.D. - Publications

Pharmacology, Analytical Chemistry, Mass Spectrometry, Pharmaceutics

110 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Rehder Silinski MA, Uenoyama T, Coleman DP, Blake JC, Thomas BF, Marusich JA, Jackson KJ, Meredith SE, Gahl RF. Analysis of Nicotine and Non-nicotine Tobacco Constituents in Aqueous Smoke/Aerosol Extracts by UHPLC and Ultraperformance Convergence Chromatography-Tandem Mass Spectrometry. Chemical Research in Toxicology. PMID 33226218 DOI: 10.1021/acs.chemrestox.0c00312  0.76
2020 Lyons EL, Leone-Kabler S, Kovach AL, Thomas BF, Howlett AC. Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells. Molecular and Cellular Neurosciences. 103566. PMID 33049367 DOI: 10.1016/j.mcn.2020.103566  0.68
2020 Gamage TF, Barrus DG, Kevin RC, Finlay DB, Lefever TW, Patel PR, Grabenauer MA, Glass M, McGregor IS, Wiley JL, Thomas BF. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018. Pharmacology, Biochemistry, and Behavior. 172918. PMID 32247816 DOI: 10.1016/J.Pbb.2020.172918  0.96
2019 Nguyen T, Gamage T, Decker AM, Barrus D, Langston TL, Li JX, Thomas BF, Zhang Y. Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators. Journal of Medicinal Chemistry. PMID 31596583 DOI: 10.1021/Acs.Jmedchem.9B01161  0.44
2019 Lefever TW, Thomas BF, Kovach AL, Snyder RW, Wiley JL. Route of administration effects on nicotine discrimination in female and male mice. Drug and Alcohol Dependence. 204: 107504. PMID 31476643 DOI: 10.1016/J.Drugalcdep.2019.06.007  0.96
2019 Nguyen T, Thomas BF, Zhang Y. Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: Current approaches for therapeutics development. Current Topics in Medicinal Chemistry. PMID 31284863 DOI: 10.2174/1568026619666190708164841  0.44
2019 Marusich JA, Wiley JL, Silinski MAR, Thomas BF, Meredith SE, Gahl RF, Jackson KJ. Comparison of Cigarette, Little Cigar, and Waterpipe Tobacco Smoke Condensate and E-Cigarette Aerosol Condensate in a Self-administration Model. Behavioural Brain Research. 112061. PMID 31254537 DOI: 10.1016/J.Bbr.2019.112061  0.96
2019 Wiley JL, Lefever TW, Michelle Glass MA, Thomas BF. Do You Feel It Now? Route of Administration and Δ-Tetrahydrocannabinol-Like Discriminative Stimulus Effects of Synthetic Cannabinoids in Mice. Neurotoxicology. PMID 30953678 DOI: 10.1016/J.Neuro.2019.04.002  0.96
2019 Kevin RC, Kovach AL, Lefever TW, Gamage TF, Wiley JL, McGregor IS, Thomas BF. Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures. Forensic Toxicology. 37: 17-26. PMID 30705707 DOI: 10.1007/S11419-018-0430-0  0.96
2018 Gamage TF, Farquhar CE, McKinnie RJ, Kevin RC, McGregor IS, Trudell M, Wiley JL, Thomas BF. Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors. The Journal of Pharmacology and Experimental Therapeutics. PMID 30552295 DOI: 10.1124/Jpet.118.254425  0.96
2018 Farquhar CE, Breivogel CS, Gamage TF, Gay EA, Thomas BF, Craft RM, Wiley JL. Sex, THC, and hormones: Effects on density and sensitivity of CB cannabinoid receptors in rats. Drug and Alcohol Dependence. 194: 20-27. PMID 30391834 DOI: 10.1016/J.Drugalcdep.2018.09.018  0.96
2018 Nguyen T, Gamage TF, Decker AM, German N, Langston TL, Farquhar CE, Kenakin TP, Wiley JL, Thomas BF, Zhang Y. Diarylureas Containing 5-Membered Heterocycles as CB1 Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation. Acs Chemical Neuroscience. PMID 30188693 DOI: 10.1021/Acschemneuro.8B00396  0.96
2018 Gamage TF, Farquhar CE, Lefever TW, Marusich JA, Kevin RC, McGregor IS, Wiley JL, Thomas BF. Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-fluoro-CUMYL-PICA. The Journal of Pharmacology and Experimental Therapeutics. PMID 29549157 DOI: 10.1124/Jpet.117.246983  0.96
2017 Marusich JA, Wiley JL, Lefever TW, Patel PR, Thomas BF. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists. Neuropharmacology. PMID 29113898 DOI: 10.1016/J.Neuropharm.2017.10.041  0.96
2017 Kevin RC, Lefever TW, Snyder RW, Patel PR, Gamage TF, Fennell TR, Wiley JL, McGregor IS, Thomas BF. Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18. Drug Testing and Analysis. PMID 28834241 DOI: 10.1002/Dta.2262  0.96
2017 Kevin RC, Lefever TW, Snyder RW, Patel PR, Fennell TR, Wiley JL, McGregor IS, Thomas BF. In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA. Forensic Toxicology. 35: 333-347. PMID 28824730 DOI: 10.1007/S11419-017-0361-1  0.96
2017 Gamage TF, Farquhar CE, Lefever TW, Thomas BF, Nguyen T, Zhang Y, Wiley JL. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators. Neuropharmacology. PMID 28803965 DOI: 10.1016/J.Neuropharm.2017.08.008  0.96
2017 Nguyen T, German N, Decker AM, Langston TL, Gamage TF, Farquhar CE, Li JX, Wiley JL, Thomas BF, Zhang Y. Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution. Journal of Medicinal Chemistry. PMID 28792219 DOI: 10.1021/Acs.Jmedchem.7B00707  0.96
2017 Moore KN, Garvin D, Thomas BF, Grabenauer M. Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods. Journal of Forensic Sciences. PMID 28597943 DOI: 10.1111/1556-4029.13367  0.48
2017 Lefever TW, Marusich JA, Thomas BF, Barrus DG, Peiper NC, Kevin RC, Wiley JL. Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice. Substance Abuse : Research and Treatment. 11: 1178221817701739. PMID 28469427 DOI: 10.1177/1178221817701739  0.96
2017 Grim TW, Morales AJ, Thomas BF, Wiley JL, Endres GW, Negus SS, Lichtman AH. Apparent CB1 receptor rimonabant affinity estimates: combination with THC and synthetic cannabinoids in the mouse in vivo triad model. The Journal of Pharmacology and Experimental Therapeutics. PMID 28442584 DOI: 10.1124/Jpet.117.240192  0.96
2017 Lefever TW, Lee YO, Kovach AL, Silinski MA, Marusich JA, Thomas BF, Wiley JL. Delivery of nicotine aerosol to mice via a modified electronic cigarette device. Drug and Alcohol Dependence. 172: 80-87. PMID 28157590 DOI: 10.1016/J.Drugalcdep.2016.12.004  0.96
2017 Thomas BF, Lefever TW, Cortes RA, Kovach AL, Cox AO, Patel PR, Pollard GT, Marusich JA, Kevin RA, Gamage TF, Wiley JL. Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences. The Journal of Pharmacology and Experimental Therapeutics. PMID 28087785 DOI: 10.1124/Jpet.116.238717  0.96
2016 Nguyen T, Li JX, Thomas BF, Wiley JL, Kenakin TP, Zhang Y. Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor. Medicinal Research Reviews. PMID 27879006 DOI: 10.1002/Med.21418  0.96
2016 Wiley JL, Marusich JA, Thomas BF. Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids. Current Topics in Behavioral Neurosciences. PMID 27753007 DOI: 10.1007/7854_2016_17  0.96
2016 Grim TW, Morales AJ, Gonek MM, Wiley JL, Thomas BF, Endres GW, Sim-Selley LJ, Selley DE, Negus SS, Lichtman AH. Stratification of cannabinoid 1 receptor (CB1R) agonist efficacy: Manipulation of CB1R density through use of transgenic mice reveals congruence between in vivo and in vitro assays. The Journal of Pharmacology and Experimental Therapeutics. PMID 27535976 DOI: 10.1124/Jpet.116.233163  0.96
2016 Seltzman HH, Shiner C, Hirt EE, Gilliam AF, Thomas BF, Maitra R, Snyder R, Black SL, Patel PR, Mulpuri Y, Spigelman I. Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain. Journal of Medicinal Chemistry. PMID 27482723 DOI: 10.1021/Acs.Jmedchem.6B00516  0.6
2016 Wiley JL, Lefever TW, Marusich JA, Grabenauer M, Moore KN, Huffman JW, Thomas BF. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice. Neuropharmacology. PMID 27449567 DOI: 10.1016/J.Neuropharm.2016.07.016  0.6
2016 Schaich CL, Grabenauer M, Thomas BF, Shaltout HA, Gallagher PE, Howlett AC, Diz DI. Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression. Frontiers in Physiology. 7: 207. PMID 27375489 DOI: 10.3389/Fphys.2016.00207  0.6
2016 Marusich JA, Lefever TW, Blough BE, Thomas BF, Wiley JL. Pharmacological Effects of Methamphetamine and Alpha-PVP Vapor and Injection. Neurotoxicology. PMID 27237056 DOI: 10.1016/J.Neuro.2016.05.015  0.96
2015 Perrey DA, Decker AM, Li JX, Gilmour BP, Thomas BF, Harris DL, Runyon SP, Zhang Y. The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. Bioorganic & Medicinal Chemistry. PMID 26216017 DOI: 10.1016/J.Bmc.2015.07.013  0.6
2015 Wiley JL, Marusich JA, Lefever TW, Antonazzo KR, Wallgren MT, Cortes RA, Patel PR, Grabenauer M, Moore KN, Thomas BF. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 26105953 DOI: 10.1124/Jpet.115.225326  0.6
2015 Nguyen T, German N, Decker AM, Li JX, Wiley JL, Thomas BF, Kenakin TP, Zhang Y. Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators. Bioorganic & Medicinal Chemistry. 23: 2195-203. PMID 25797163 DOI: 10.1016/J.Bmc.2015.02.058  0.6
2015 Perrey DA, German NA, Decker AM, Thorn D, Li JX, Gilmour BP, Thomas BF, Harris DL, Runyon SP, Zhang Y. Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor. Acs Chemical Neuroscience. 6: 599-614. PMID 25643283 DOI: 10.1016/J.Drugalcdep.2015.07.659  0.6
2015 Schaich CL, Shaltout HA, Grabenauer M, Thomas BF, Gallagher PE, Howlett AC, Diz DI. Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity. Journal of Cardiovascular Pharmacology. 65: 473-9. PMID 25636077 DOI: 10.1097/Fjc.0000000000000216  0.6
2015 Wiley JL, Marusich JA, Thomas BF, Jackson KJ. Determination of behaviorally effective tobacco constituent doses in rats. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 17: 368-71. PMID 25271188 DOI: 10.1093/Ntr/Ntu194  0.6
2015 Zhang Y, Perrey DA, Harris DL, German NA, Decker AM, Gilmour BP, Thomas BF. Structure-activity relationship studies on the tetrahydroisoquinoline-based orexin 1 receptor antagonists: The 1-benzyl position Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.765  0.44
2014 German N, Decker AM, Gilmour BP, Gay EA, Wiley JL, Thomas BF, Zhang Y. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1). Journal of Medicinal Chemistry. 57: 7758-69. PMID 25162172 DOI: 10.1021/Jm501042U  0.6
2014 Perrey DA, Gilmour BP, Thomas BF, Zhang Y. Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers. Acs Medicinal Chemistry Letters. 5: 634-8. PMID 24944734 DOI: 10.1021/Ml4004759  0.6
2014 Pozor MA, Zambrano G, Roser J, Hess R, Runyon S, Runcan E, Thomas BF, Dymock D, Macpherson ML, Troedsson MH, Kelleman A. Acute and chronic effects of a contraceptive compound RTI-4587-073(l) on testicular histology and endocrine function in miniature horse stallions. Reproduction in Domestic Animals = Zuchthygiene. 49: 392-402. PMID 24593030 DOI: 10.1111/Rda.12286  0.6
2014 Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, Marusich JA, Wegner S, Olive MF. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addiction Biology. 19: 165-74. PMID 22784198 DOI: 10.1111/J.1369-1600.2012.00474.X  0.6
2013 German NA, Decker AM, Gilmour BP, Thomas BF, Zhang Y. Truncated Orexin Peptides: Structure-Activity Relationship Studies. Acs Medicinal Chemistry Letters. 4: 1224-1227. PMID 24707347 DOI: 10.1021/Ml400333A  0.6
2013 Pozor MA, Macpherson ML, McDonnell SM, Nollin M, Roser JF, Love C, Runyon S, Thomas BF, Troedsson MH. Indenopyride derivative RTI-4587-073(l): a candidate for male contraception in stallions. Theriogenology. 80: 1006-16. PMID 23998737 DOI: 10.1016/J.Theriogenology.2013.07.029  0.6
2013 Perrey DA, German NA, Gilmour BP, Li JX, Harris DL, Thomas BF, Zhang Y. Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. Journal of Medicinal Chemistry. 56: 6901-16. PMID 23941044 DOI: 10.1021/Jm400720H  0.6
2013 Wiley JL, Marusich JA, Lefever TW, Grabenauer M, Moore KN, Thomas BF. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles. Neuropharmacology. 75: 145-54. PMID 23916483 DOI: 10.1016/J.Neuropharm.2013.07.022  0.6
2013 Kotsikorou E, Navas F, Roche MJ, Gilliam AF, Thomas BF, Seltzman HH, Kumar P, Song ZH, Hurst DP, Lynch DL, Reggio PH. The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528). Journal of Medicinal Chemistry. 56: 6593-612. PMID 23855811 DOI: 10.1021/Jm400070U  0.6
2013 Hatsukami DK, Heishman SJ, Vogel RI, Denlinger RL, Roper-Batker AN, Mackowick KM, Jensen J, Murphy SE, Thomas BF, Donny E. Dose-response effects of spectrum research cigarettes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 1113-21. PMID 23178320 DOI: 10.1093/Ntr/Nts247  0.6
2013 Thomas BF, Pollard GT, Grabenauer M. Analytical surveillance of emerging drugs of abuse and drug formulations. Life Sciences. 92: 512-9. PMID 23154240 DOI: 10.1016/J.Lfs.2012.10.031  0.6
2012 Wiley JL, Marusich JA, Zhang Y, Fulp A, Maitra R, Thomas BF, Mahadevan A. Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice. European Journal of Pharmacology. 695: 62-70. PMID 22975289 DOI: 10.1016/J.Ejphar.2012.08.019  0.6
2012 Murineddu G, Asproni B, Ruiu S, Deligia F, Falzoi M, Pau A, Thomas BF, Zhang Y, Pinna GA, Pani L, Lazzari P. Tricyclic Pyrazoles. Part 5. Novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 Ligands Using Molecular Hybridization Based on Scaffold Hopping. The Open Medicinal Chemistry Journal. 6: 1-14. PMID 22876271 DOI: 10.2174/1874104501206010001  0.6
2012 Grabenauer M, Krol WL, Wiley JL, Thomas BF. Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs. Analytical Chemistry. 84: 5574-81. PMID 22724537 DOI: 10.1021/Ac300509H  0.6
2012 Cox AO, Daw RC, Mason MD, Grabenauer M, Pande PG, Davis KH, Wiley JL, Stout PR, Thomas BF, Huffman JW. Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids. Journal of Analytical Toxicology. 36: 293-302. PMID 22582264 DOI: 10.1093/Jat/Bks025  0.6
2011 Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF. Hijacking of Basic Research: The Case of Synthetic Cannabinoids. Methods Report (Rti Press). 2011. PMID 23397508 DOI: 10.3768/rtipress.2011.op.0007.1111  0.96
2011 Perrey DA, Gilmour BP, Runyon SP, Thomas BF, Zhang Y. Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21: 2980-5. PMID 21478014 DOI: 10.1016/J.Bmcl.2011.03.048  0.6
2010 Zhang Y, Gilliam A, Maitra R, Damaj MI, Tajuba JM, Seltzman HH, Thomas BF. Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor. Journal of Medicinal Chemistry. 53: 7048-60. PMID 20845959 DOI: 10.1021/Jm1006676  0.6
2010 Walentiny DM, Vann RE, Warner JA, King LS, Seltzman HH, Navarro HA, Twine CE, Thomas BF, Gilliam AF, Gilmour BP, Carroll FI, Wiley JL. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology. 210: 275-84. PMID 20354680 DOI: 10.1007/S00213-010-1827-6  0.6
2010 Lindeblad MO, Bauer KS, Zakharov AD, Hill JM, Green JS, Thomas BF, Schwartz A, Kapetanovic IM, Lyubimov A. Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes. Chemico-Biological Interactions. 183: 317-26. PMID 19836365 DOI: 10.1016/J.Cbi.2009.10.004  0.6
2010 Thomas BF, Beardsley PM, Seltzman HH. Current considerations for development of cannabinoid receptor 1 antagonists (Drug Development Research (2009) 70, 8 (525-526) DOI: 10.1002/ddr.20332) Drug Development Research. 71: 159. DOI: 10.1002/Ddr.20361  0.6
2009 Beardsley PM, Thomas BF, McMahon LR. Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders. International Review of Psychiatry (Abingdon, England). 21: 134-42. PMID 19367507 DOI: 10.1080/09540260902782786  0.6
2009 Burgess JP, Green JS, Hill JM, Zhan Q, Lindeblad M, Lyubimov A, Kapetanovic IM, Schwartz A, Thomas BF. Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1089-97. PMID 19196848 DOI: 10.1124/Dmd.108.023614  0.6
2009 Thomas BF. Neuroanatomical basis for therapeutic applications of cannabinoid receptor 1 antagonists Drug Development Research. 70: 527-554. DOI: 10.1002/Ddr.20333  0.6
2008 Zhang Y, Burgess JP, Brackeen M, Gilliam A, Mascarella SW, Page K, Seltzman HH, Thomas BF. Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations. Journal of Medicinal Chemistry. 51: 3526-39. PMID 18512901 DOI: 10.1021/Jm8000778  0.6
2007 Rees VW, Wayne GF, Thomas BF, Connolly GN. Physical design analysis and mainstream smoke constituent yields of the new potential reduced exposure product, Marlboro UltraSmooth. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1197-206. PMID 17978995 DOI: 10.1080/14622200701648375  0.6
2007 Bourne C, Roy S, Wiley JL, Martin BR, Thomas BF, Mahadevan A, Razdan RK. Novel, potent THC/anandamide (hybrid) analogs. Bioorganic & Medicinal Chemistry. 15: 7850-64. PMID 17827022 DOI: 10.1016/J.Bmc.2007.08.039  0.6
2006 Thomas BF, Zhang Y, Brackeen M, Page KM, Mascarella SW, Seltzman HH. Conformational characteristics of the interaction of SR141716A with the CB1 cannabinoid receptor as determined through the use of conformationally constrained analogs. The Aaps Journal. 8: E665-71. PMID 17233530 DOI: 10.1208/Aapsj080476  0.6
2006 Burgess JP, Wintermute JS, Thomas BF, Kapetanovic IM. Complete 1H and 13C assignments of fluorinated analogs of dehydroepiandrosterone. Magnetic Resonance in Chemistry : Mrc. 44: 1051-3. PMID 16835888 DOI: 10.1002/Mrc.1874  0.6
2006 Paine MF, Widmer WW, Hart HL, Pusek SN, Beavers KL, Criss AB, Brown SS, Thomas BF, Watkins PB. A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. The American Journal of Clinical Nutrition. 83: 1097-105. PMID 16685052 DOI: 10.1093/Ajcn/83.5.1097  0.6
2005 Beardsley PM, Thomas BF. Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. Behavioural Pharmacology. 16: 275-96. PMID 16148435 DOI: 10.1097/00008877-200509000-00003  0.6
2005 Thomas BF, Francisco ME, Seltzman HH, Thomas JB, Fix SE, Schulz AK, Gilliam AF, Pertwee RG, Stevenson LA. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities. Bioorganic & Medicinal Chemistry. 13: 5463-74. PMID 15994087 DOI: 10.1016/J.Bmc.2005.06.005  0.6
2005 Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. The Journal of Pharmacology and Experimental Therapeutics. 314: 329-37. PMID 15831444 DOI: 10.1124/Jpet.104.080739  0.6
2004 Fischer L, Mahoney C, Jeffcoat AR, Koch MA, Thomas BE, Valentine JL, Stinchcombe T, Boan J, Crowell JA, Zeisel SH. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia. Nutrition and Cancer. 48: 160-70. PMID 15231450 DOI: 10.1207/S15327914Nc4802_5  0.6
2003 Hunt PA, Koehler KE, Susiarjo M, Hodges CA, Ilagan A, Voigt RC, Thomas S, Thomas BF, Hassold TJ. Bisphenol a exposure causes meiotic aneuploidy in the female mouse. Current Biology : Cb. 13: 546-53. PMID 12676084 DOI: 10.1016/S0960-9822(03)00189-1  0.6
2003 Huffman JW, Miller JR, Liddle J, Yu S, Thomas BF, Wiley JL, Martin BR. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols. Bioorganic & Medicinal Chemistry. 11: 1397-410. PMID 12628666 DOI: 10.1016/S0968-0896(02)00649-1  0.6
2003 Francisco MEY, Burgess JP, George C, Bailey GS, Gilliam AF, Seltzman HH, Thomas BF. Structure elucidation of a novel ring-constrained biaryl pyrazole CB 1 cannabinoid receptor antagonist Magnetic Resonance in Chemistry. 41: 265-268. DOI: 10.1002/Mrc.1174  0.6
2002 Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA, Zeisel SH. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. The American Journal of Clinical Nutrition. 76: 1126-37. PMID 12399289 DOI: 10.1093/Ajcn/76.5.1126  0.6
2002 Tyl RW, Myers CB, Marr MC, Thomas BF, Keimowitz AR, Brine DR, Veselica MM, Fail PA, Chang TY, Seely JC, Joiner RL, Butala JH, Dimond SS, Cagen SZ, Shiotsuka RN, et al. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicological Sciences : An Official Journal of the Society of Toxicology. 68: 121-46. PMID 12075117 DOI: 10.1093/Toxsci/68.1.121  0.6
2002 Francisco ME, Seltzman HH, Gilliam AF, Mitchell RA, Rider SL, Pertwee RG, Stevenson LA, Thomas BF. Synthesis and structure-activity relationships of amide and hydrazide analogues of the cannabinoid CB(1) receptor antagonist N-(piperidinyl)- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716). Journal of Medicinal Chemistry. 45: 2708-19. PMID 12061874 DOI: 10.1021/Jm010498V  0.6
2002 Martin BR, Jefferson RG, Winckler R, Wiley JL, Thomas BF, Crocker PJ, Williams W, Razdan RK. Assessment of structural commonality between tetrahydrocannabinol and anandamide. European Journal of Pharmacology. 435: 35-42. PMID 11790376 DOI: 10.1016/S0014-2999(01)01527-8  0.6
2002 Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ, Heizer WD, Thomas BF, Hill JM, Crowell JA, Zeisel SH. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. The American Journal of Clinical Nutrition. 75: 126-36. PMID 11756070 DOI: 10.1093/Ajcn/75.1.126  0.6
2001 Thomas BF, Zeisel SH, Busby MG, Hill JM, Mitchell RA, Scheffler NM, Brown SS, Bloeden LT, Dix KJ, Jeffcoat AR. Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography. B, Biomedical Sciences and Applications. 760: 191-205. PMID 11530977 DOI: 10.1016/S0378-4347(01)00269-9  0.6
2001 Dix KJ, Coleman DP, Fossett JE, Gaudette NF, Stanley AP, Thomas BF, Jeffcoat AR. Disposition of propargyl alcohol in rat and mouse after intravenous, oral, dermal and inhalation exposure. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 31: 357-75. PMID 11513248 DOI: 10.1080/00498250110053228  0.6
2001 De Costa KS, Black SR, Thomas BF, Burgess JP, Mathews JM. Metabolism and disposition of alpha-methylstyrene in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 29: 166-71. PMID 11159807  0.6
2000 Keimowitz AR, Martin BR, Razdan RK, Crocker PJ, Mascarella SW, Thomas BF. QSAR analysis of Delta(8)-THC analogues: relationship of side-chain conformation to cannabinoid receptor affinity and pharmacological potency. Journal of Medicinal Chemistry. 43: 59-70. PMID 10633038 DOI: 10.1021/jm9902281  0.6
1999 Bowman BP, Vaughan SR, Walker QD, Davis SL, Little PJ, Scheffler NM, Thomas BF, Kuhn CM. Effects of sex and gonadectomy on cocaine metabolism in the rat. The Journal of Pharmacology and Experimental Therapeutics. 290: 1316-23. PMID 10454509  0.6
1999 Buckley LA, Coleman DP, Burgess JP, Thomas BF, Burka LT, Jeffcoat AR. Identification of urinary metabolites of isoprene in rats and comparison with mouse urinary metabolites. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 27: 848-54. PMID 10383931  0.6
1999 Thomas BF, Burgess JP, Coleman DP, Scheffler NM, Jeffcoat AR, Dix KJ. Isolation and identification of novel metabolites of gemfibrozil in rat urine. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 27: 147-57. PMID 9884324  0.6
1998 Reggio PH, Basu-Dutt S, Barnett-Norris J, Castro MT, Hurst DP, Seltzman HH, Roche MJ, Gilliam AF, Thomas BF, Stevenson LA, Pertwee RG, Abood ME. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes. Journal of Medicinal Chemistry. 41: 5177-87. PMID 9857088 DOI: 10.1021/Jm9801197  0.6
1998 Thomas BF, Gilliam AF, Burch DF, Roche MJ, Seltzman HH. Comparative receptor binding analyses of cannabinoid agonists and antagonists. The Journal of Pharmacology and Experimental Therapeutics. 285: 285-92. PMID 9536023  0.6
1997 Seltzman HH, Fleming DN, Thomas BF, Gilliam AF, McCallion DS, Pertwee RG, Compton DR, Martin BR. Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. Journal of Medicinal Chemistry. 40: 3626-34. PMID 9357529 DOI: 10.1021/Jm9702950  0.6
1997 Dutta AK, Ryan W, Thomas BF, Singer M, Compton DR, Martin BR, Razdan RK. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs). Bioorganic & Medicinal Chemistry. 5: 1591-600. PMID 9313864 DOI: 10.1016/S0968-0896(97)00111-9  0.6
1996 Ley FR, Jeffcoat AR, Thomas BF. Determination of ibogaine in plasma by gas chromatography--chemical ionization mass spectrometry. Journal of Chromatography. A. 723: 101-9. PMID 8819825 DOI: 10.1016/0021-9673(95)00827-6  0.6
1996 Mathews JM, deCosta K, Thomas BF. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 24: 702-10. PMID 8818565  0.6
1996 Lever JR, Scheffel U, Stathis M, Seltzman HH, Wyrick CD, Abraham P, Parham K, Thomas BF, Boja JW, Kuhar MJ, Carroll FI. Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121). Nuclear Medicine and Biology. 23: 277-84. PMID 8782237 DOI: 10.1016/0969-8051(95)02074-8  0.6
1996 Thomas BF, Adams IB, Mascarella SW, Martin BR, Razdan RK. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. Journal of Medicinal Chemistry. 39: 471-9. PMID 8558515 DOI: 10.1021/jm9505167  0.6
1995 Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. The Journal of Pharmacology and Experimental Therapeutics. 273: 1172-81. PMID 7791088  0.6
1994 Thomas BF, Jeffcoat AR, Myers MW, Mathews JM, Cook CE. Determination of l-alpha-acetylmethadol, l-alpha-noracetylmethadol and l-alpha-dinoracetylmethadol in plasma by gas chromatography-mass spectrometry. Journal of Chromatography. B, Biomedical Applications. 655: 201-11. PMID 8081466 DOI: 10.1016/0378-4347(94)00097-2  0.6
1993 Thomas BF, Martin BR. Further characterization of the cannabinoid receptor with 3H-11-OH-Δ9- THC-DMH binding in rat brain slices: Autoradiography, displacement studies and correlation to in vivo pharmacological potencies Nida Research Monograph Series. 375.  0.6
1992 Thomas BF, Wei X, Martin BR. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH. The Journal of Pharmacology and Experimental Therapeutics. 263: 1383-90. PMID 1335065  0.6
1991 Thomas BF, Compton DR, Martin BR, Semus SF. Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis. Molecular Pharmacology. 40: 656-65. PMID 1944237  0.6
1991 Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry, and Behavior. 40: 471-8. PMID 1666911 DOI: 10.1016/0091-3057(91)90349-7  0.6
1990 Thomas BF, Compton DR, Martin BR. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. The Journal of Pharmacology and Experimental Therapeutics. 255: 624-30. PMID 2173751  0.6
1990 Thomas BF, Martin BR. In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl) phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol, a synthetic bicyclic cannabinoid analog. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 18: 1046-54. PMID 1981511  0.6
1989 Thomas BF, Martin BR. Identification of metabolites of CP-55,940 formed in-vitro by mouse livers. Nida Research Monograph. 95: 287-8. PMID 2640971  0.6
1988 Lue LP, Scimeca JA, Thomas BF, Martin BR. Pyrolytic fate of piperidinocyclohexanecarbonitrile, a contaminant of phencyclidine, during smoking. Journal of Analytical Toxicology. 12: 57-61. PMID 3379921 DOI: 10.1093/Jat/12.2.57  0.6
1988 Thomas BF, Bowman ER, Tucker SM, Aceto MD. Plasma concentrations of nicotine in rats during tolerance and chronic exposure studies. European Journal of Drug Metabolism and Pharmacokinetics. 13: 247-52. PMID 3243318 DOI: 10.1007/BF03190086  0.6
1988 Lyddane JE, Thomas BF, Compton DR, Martin BR. Modification of phencyclidine intoxification and biodisposition by charcoal and other treatments. Pharmacology, Biochemistry, and Behavior. 30: 371-7. PMID 3174769 DOI: 10.1016/0091-3057(88)90470-4  0.6
1986 Thomas BF, Lyddane JE, Martin BR. Modification of behavioral effects and biodisposition of phencyclidine in rats by ammonium chloride. The Journal of Pharmacology and Experimental Therapeutics. 239: 48-54. PMID 3761197  0.6
1986 Lue LP, Scimeca JA, Thomas BF, Martin BR. Identification and quantification of phencyclidine pyrolysis products formed during smoking. Journal of Analytical Toxicology. 10: 81-6. PMID 3724075 DOI: 10.1093/Jat/10.3.81  0.6
1985 Reynolds ML, Little PJ, Thomas BF, Bagley RB, Martin BR. Relationship between the biodisposition of [3H]soman and its pharmacological effects in mice. Toxicology and Applied Pharmacology. 80: 409-20. PMID 4035696 DOI: 10.1016/0041-008X(85)90385-0  0.6
1985 Martin BR, Thomas BF. Effect of urine acidification on the biodisposition of 3H-phencyclidine in rats Federation Proceedings. 44: No. 6200.  0.6
Show low-probability matches.